VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹45 Cr | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr |
What is the latest Consolidated Net Profit of VENUS REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹62 Cr |
How is Consolidated Net Profit of VENUS REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 59.05 | |
| Mar2024 | ₹28 Cr | 7.25 | |
| Mar2023 | ₹27 Cr | -34.77 | |
| Mar2022 | ₹41 Cr | -34.07 | |
| Mar2021 | ₹62 Cr | - | |
Compare Consolidated Net Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹998.6 Cr | 2.7% | 68.6% | 137.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 2.7% |
68.6% |
137.6% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses